Lundbeck
HLUN-B.CO
S$6.99
Share price
0.93%
Change (1 day)
-12.01%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$5.50 Billion
According to Lundbeck's latest financial reports the company's total liabilities are S$5.50 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Lundbeck - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$6.06 B | 101.77% |
| 2023-12-31 | S$3.00 B | -6.65% |
| 2022-12-31 | S$3.21 B | -4.49% |
| 2021-12-31 | S$3.37 B | -19.13% |
| 2020-12-31 | S$4.16 B | -3.44% |
| 2019-12-31 | S$4.31 B | 135.38% |
| 2018-12-31 | S$1.83 B | 12.26% |
| 2017-12-31 | S$1.63 B | -24.21% |
| 2016-12-31 | S$2.15 B | -17.1% |
| 2015-12-31 | S$2.59 B | -0.54% |
| 2014-12-31 | S$2.61 B | 9.58% |
| 2013-12-31 | S$2.38 B | 31.49% |
| 2012-12-31 | S$1.81 B | 3.63% |
| 2011-12-31 | S$1.75 B | 10.62% |
| 2010-12-31 | S$1.58 B | -29.71% |
| 2009-12-31 | S$2.25 B | 67.15% |
| 2008-12-31 | S$1.34 B | -6.98% |
| 2007-12-31 | S$1.44 B | 9.43% |
| 2006-12-31 | S$1.32 B | 21.33% |
| 2005-12-31 | S$1.09 B | 0.05% |
| 2004-12-31 | S$1.08 B |